Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jan;102(1):62-69.
doi: 10.1002/cyto.b.21995. Epub 2021 Feb 25.

Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia

Affiliations

Flow cytometry detection of CD138 expression continuum between monotypic B and plasma cells is associated with both high IgM peak levels and MYD88 mutation and contributes to diagnosis of Waldenström macroglobulinemia

Mylene Gayet et al. Cytometry B Clin Cytom. 2022 Jan.

Abstract

Background: Differential diagnosis of Waldenström macroglobulinemia (WM) with other indolent B-cell malignancies is still a challenge. Here, we propose an original and simple analysis of routine flow cytometry (FCM) unraveling the characteristic ongoing plasma cell (PC) differentiation of WM tumor B-cells.

Methods: FCM analysis of both B-cells and PC was performed on a series of 77 patients with IgM peak. MYD88 and CXCR4 mutations were studied using an allele-specific PCR and by high throughput sequencing.

Results: Twenty seven (35%), 46 (58%) and 4 (5%) patients were classified as WM, IgM monoclonal gammopathy of undetermined significance (MGUS) or other B-NHL respectively. MYD88 mutation was found in 25/27 WM (93%) and in 29/46 MGUS (63%). Using FCM, monotypic B-cells were found in 27/27 WM (100%) and 34/46 MGUS (74%). Monotypic CD138pos/CD38pos PCs were detected in 23/27 WM (85%) and 25/46 MGUS (54%). Highlighting the ongoing PC differentiation of WM tumor B-cells by FCM, we evidenced a CD138 expression continuum between monotypic B-cells and PCs. This pattern remained absent in control samples and was significantly associated with higher IgM peaks (p = 6.10-5 ) and MYD88 mutations (p = 10-3 ) in both WM and MGUS cases.

Conclusions: FCM exploration of both B-cells and PC led to identify a CD138 expression continuum as an objective marker of ongoing PC differentiation of WM tumor cells and was strongly associated with increased IgM peak levels and MYD88 mutations. This approach could contribute to place FCM at the forefront of WM diagnosis.

Keywords: IgM; MYD88; Waldenström macroglobulinaemia/lymphoplasmatic lymphoma; flow cytometry; plasma cell.

PubMed Disclaimer

References

REFERENCES

    1. Baldini, L., Goldaniga, M., Guffanti, A., Broglia, C., Cortelazzo, S., Rossi, A., Morra, E., Colombi, M., Callea, V., Pogliani, E., Ilariucci, F., Luminari, S., Morel, P., Merlini, G., & Gobbi, P. (2005). Immunoglobulin M monoclonal gammopathies of undetermined significance and indolent Waldenstrom's macroglobulinemia recognize the same determinants of evolution into symptomatic lymphoid disorders: Proposal for a common prognostic scoring system. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 23, 4662-4668.
    1. Batata, A., & Shen, B. (1993). Diagnostic value of clonality of surface immunoglobulin light and heavy chains in malignant lymphoproliferative disorders. American Journal of Hematology, 43, 265-270.
    1. Cao, X.-X., Meng, Q., Mao, Y.-Y., Su, W., Zhen, J.-F., Shen, K.-N., Zhang, C.-L., Huang, X.-F., Duan, M.-H., Zhang, W., Zhu, T.-N., Cai, H.-C., Chen, M., Zhou, D.-B., & Li, J. (2016). The clinical spectrum of IgM monoclonal gammopathy: A single center retrospective study of 377 patients. Leukemia Research, 46, 85-88.
    1. Dwivedi, A. K., Mallawaarachchi, I., & Alvarado, L. A. (2017). Analysis of small sample size studies using nonparametric bootstrap test with pooled resampling method. Statistics in Medicine, 36, 2187-2205.
    1. Frébet, E., Abraham, J., Geneviève, F., Lepelley, P., Daliphard, S., Bardet, V., Amsellem, S., Guy, J., Mullier, F., Durrieu, F., Venon, M.-D., Leleu, X., Jaccard, A., Faucher, J.-L., Béné, M. C., & Feuillard, J. (2011). GEIL Groupe d'Etude Immunologique des Leucémies Study Group. A GEIL flow cytometry consensus proposal for quantification of plasma cells: Application to differential diagnosis between MGUS and myeloma. Cytometry. Part B, Clinical Cytometry, 80, 176-185.

Publication types

MeSH terms